- Home
- JFR vs AXGN Comparison
JFR vs AXGN Comparison
Compare JFR & AXGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | JFR | AXGN |
|---|---|---|
| Founded | 2004 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trusts Except Educational Religious and Charitable | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | JFR | AXGN |
|---|---|---|
| Price | $7.76 | $29.89 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $33.67 |
| AVG Volume (30 Days) | 621.7K | ★ 992.8K |
| Earning Date | 01-01-0001 | 10-29-2025 |
| Dividend Yield | ★ 11.31% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $214,709,000.00 |
| Revenue This Year | N/A | $21.57 |
| Revenue Next Year | N/A | $15.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 18.72 |
| 52 Week Low | $7.61 | $9.22 |
| 52 Week High | $8.82 | $34.24 |
Technical Indicators
Market Signals| Indicator | JFR | AXGN |
|---|---|---|
| Relative Strength Index (RSI) | 37.01 | 61.08 |
| Support Level | $7.80 | $28.88 |
| Resistance Level | $7.96 | $30.76 |
| Average True Range (ATR) | 0.05 | 1.48 |
| MACD | -0.00 | -0.25 |
| Stochastic Oscillator | 13.04 | 35.46 |
Price Performance
Historical ComparisonAbout JFR Nuveen Floating Rate Income Fund
Nuveen Floating Rate Income Fund is a diversified closed-end management investment company. Its investment objective is to achieve a high level of current income. The fund invests a majority of its managed assets in secured Senior Loans and unsecured Senior Loans, with an average duration of one year or less, in which unsecured Senior Loans will be, at the time of investment, investment grade quality.
About AXGN Axogen Inc.
Axogen Inc is engaged in the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. The company provides clinically, economically effective repair solutions for surgeons and health care providers. Its products include Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard Nerve Cap and Avive Soft Tissue Membrane. It also offers an Axotouch Two-Point Discriminator used to measure the innervation density of any surface area of the skin. Its products are available in the United States, Canada, Germany, the United Kingdom, Spain, South Korea, and several other countries.